Lipnicki Darren M, Crawford John D, Dutta Rajib, Thalamuthu Anbupalam, Kochan Nicole A, Andrews Gavin, Lima-Costa M Fernanda, Castro-Costa Erico, Brayne Carol, Matthews Fiona E, Stephan Blossom C M, Lipton Richard B, Katz Mindy J, Ritchie Karen, Scali Jacqueline, Ancelin Marie-Laure, Scarmeas Nikolaos, Yannakoulia Mary, Dardiotis Efthimios, Lam Linda C W, Wong Candy H Y, Fung Ada W T, Guaita Antonio, Vaccaro Roberta, Davin Annalisa, Kim Ki Woong, Han Ji Won, Kim Tae Hui, Anstey Kaarin J, Cherbuin Nicolas, Butterworth Peter, Scazufca Marcia, Kumagai Shuzo, Chen Sanmei, Narazaki Kenji, Ng Tze Pin, Gao Qi, Reppermund Simone, Brodaty Henry, Lobo Antonio, Lopez-Anton Raúl, Santabárbara Javier, Sachdev Perminder S
Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.
Rene Rachou Research Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
PLoS Med. 2017 Mar 21;14(3):e1002261. doi: 10.1371/journal.pmed.1002261. eCollection 2017 Mar.
The prevalence of dementia varies around the world, potentially contributed to by international differences in rates of age-related cognitive decline. Our primary goal was to investigate how rates of age-related decline in cognitive test performance varied among international cohort studies of cognitive aging. We also determined the extent to which sex, educational attainment, and apolipoprotein E ε4 allele (APOE*4) carrier status were associated with decline.
We harmonized longitudinal data for 14 cohorts from 12 countries (Australia, Brazil, France, Greece, Hong Kong, Italy, Japan, Singapore, Spain, South Korea, United Kingdom, United States), for a total of 42,170 individuals aged 54-105 y (42% male), including 3.3% with dementia at baseline. The studies began between 1989 and 2011, with all but three ongoing, and each had 2-16 assessment waves (median = 3) and a follow-up duration of 2-15 y. We analyzed standardized Mini-Mental State Examination (MMSE) and memory, processing speed, language, and executive functioning test scores using linear mixed models, adjusted for sex and education, and meta-analytic techniques. Performance on all cognitive measures declined with age, with the most rapid rate of change pooled across cohorts a moderate -0.26 standard deviations per decade (SD/decade) (95% confidence interval [CI] [-0.35, -0.16], p < 0.001) for processing speed. Rates of decline accelerated slightly with age, with executive functioning showing the largest additional rate of decline with every further decade of age (-0.07 SD/decade, 95% CI [-0.10, -0.03], p = 0.002). There was a considerable degree of heterogeneity in the associations across cohorts, including a slightly faster decline (p = 0.021) on the MMSE for Asians (-0.20 SD/decade, 95% CI [-0.28, -0.12], p < 0.001) than for whites (-0.09 SD/decade, 95% CI [-0.16, -0.02], p = 0.009). Males declined on the MMSE at a slightly slower rate than females (difference = 0.023 SD/decade, 95% CI [0.011, 0.035], p < 0.001), and every additional year of education was associated with a rate of decline slightly slower for the MMSE (0.004 SD/decade less, 95% CI [0.002, 0.006], p = 0.001), but slightly faster for language (-0.007 SD/decade more, 95% CI [-0.011, -0.003], p = 0.001). APOE*4 carriers declined slightly more rapidly than non-carriers on most cognitive measures, with processing speed showing the greatest difference (-0.08 SD/decade, 95% CI [-0.15, -0.01], p = 0.019). The same overall pattern of results was found when analyses were repeated with baseline dementia cases excluded. We used only one test to represent cognitive domains, and though a prototypical one, we nevertheless urge caution in generalizing the results to domains rather than viewing them as test-specific associations. This study lacked cohorts from Africa, India, and mainland China.
Cognitive performance declined with age, and more rapidly with increasing age, across samples from diverse ethnocultural groups and geographical regions. Associations varied across cohorts, suggesting that different rates of cognitive decline might contribute to the global variation in dementia prevalence. However, the many similarities and consistent associations with education and APOE genotype indicate a need to explore how international differences in associations with other risk factors such as genetics, cardiovascular health, and lifestyle are involved. Future studies should attempt to use multiple tests for each cognitive domain and feature populations from ethnocultural groups and geographical regions for which we lacked data.
痴呆症的患病率在世界各地有所不同,这可能与年龄相关认知衰退率的国际差异有关。我们的主要目标是调查在认知老化的国际队列研究中,认知测试表现的年龄相关衰退率是如何变化的。我们还确定了性别、受教育程度和载脂蛋白E ε4等位基因(APOE*4)携带者状态与衰退相关的程度。
我们整合了来自12个国家(澳大利亚、巴西、法国、希腊、中国香港、意大利、日本、新加坡、西班牙、韩国、英国、美国)14个队列的纵向数据,共计42170名年龄在54 - 105岁的个体(42%为男性),其中3.3%在基线时患有痴呆症。这些研究始于1989年至2011年之间,除三项研究外其他均仍在进行,每项研究有2 - 16次评估波次(中位数 = 3),随访时间为2 - 15年。我们使用线性混合模型分析标准化的简易精神状态检查表(MMSE)以及记忆、处理速度、语言和执行功能测试分数,并对性别和教育进行了调整,同时运用了荟萃分析技术。所有认知指标的表现均随年龄下降,各队列合并后变化最快的是处理速度,为每十年适度下降 - 0.26标准差(SD/十年)(95%置信区间[CI][-0.35, -0.16],p < 0.001)。衰退率随年龄略有加速,执行功能每增加一个十年显示出最大的额外衰退率(-0.07 SD/十年,95% CI [-0.10, -0.03],p = 0.002)。各队列之间的关联存在相当程度的异质性,包括亚洲人在MMSE上的衰退略快(p = 0.021)(-0.20 SD/十年,95% CI [-0.28, -0.12],p < 0.001),高于白人(-0.09 SD/十年,95% CI [-0.16, -0.02],p = 0.009)。男性在MMSE上的衰退速度略慢于女性(差异 = 0.023 SD/十年,95% CI [0.011, 0.035],p < 0.001),每增加一年教育,MMSE的衰退率略慢(少0.004 SD/十年,95% CI [0.002, 0.006],p = 0.001),但语言衰退率略快(多 - 0.007 SD/十年,95% CI [-0.011, -0.003],p = 0.001)。在排除基线痴呆病例后重复分析时,发现了相同的总体结果模式。我们仅使用一项测试来代表认知领域,尽管这是一个典型测试,但我们仍敦促谨慎将结果推广到各个领域,而不是将其视为特定测试的关联。本研究缺乏来自非洲、印度和中国大陆的队列。
在来自不同种族文化群体和地理区域的样本中,认知表现随年龄下降,且随年龄增长下降更快。各队列之间的关联有所不同,这表明不同的认知衰退率可能导致痴呆症患病率的全球差异。然而,与教育和APOE基因型的许多相似性及一致关联表明,有必要探索与其他风险因素(如遗传学、心血管健康和生活方式)的关联在国际上的差异是如何涉及其中的。未来的研究应尝试针对每个认知领域使用多项测试,并纳入我们缺乏数据的种族文化群体和地理区域的人群。